These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3677074)

  • 1. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
    Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
    J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents.
    Auclair C; Schwaller MA; René B; Banoun H; Saucier JM; Larsen AK
    Anticancer Drug Des; 1988 Aug; 3(2):133-44. PubMed ID: 2841946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
    Djuric Z; Everett CK; Valeriote FA
    Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
    Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
    J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].
    Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(18):1365-7. PubMed ID: 815025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).
    Paoletti C; Le Pecq JB; Dat-Xuong N; Juret P; Garnier H; Amiel JL; Rouesse J
    Recent Results Cancer Res; 1980; 74():107-23. PubMed ID: 7003658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some antitumor derivatives of ellipticine deprived of mutagenic properties.
    Lecointe P; Lesca P; Cros S; Paoletti C
    Chem Biol Interact; 1978 Jan; 20(1):113-21. PubMed ID: 630641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
    Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
    J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
    Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
    Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of metastatic renal cancer in adults with elliptinium acetate].
    Amiel JL; Rouessé J; Droz JP; Caille P; Travagli JP; Théodore C; Le Chevalier T; Ducret JP; Bidart M; Garnier HS
    Presse Med; 1984 Jun; 13(25):1555-7. PubMed ID: 6234539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
    Honda T; Kato M; Inoue M; Shimamoto T; Shima K; Nakanishi T; Yoshida T; Noguchi T
    J Med Chem; 1988 Jul; 31(7):1295-305. PubMed ID: 3385725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of elliptinium.
    Mauffret O; Rene B; Convert O; Monnot M; Lescot E; Fermandjian S
    Biopolymers; 1991 Oct; 31(11):1325-41. PubMed ID: 1777583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.
    DeMarini DM; Cros S; Paoletti C; Lecointe P; Hsie AW
    Cancer Res; 1983 Aug; 43(8):3544-52. PubMed ID: 6344986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition.
    Le Mée S; Pierré A; Markovits J; Atassi G; Jacquemin-Sablon A; Saucier JM
    Mol Pharmacol; 1998 Feb; 53(2):213-20. PubMed ID: 9463478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
    Auclair C; Dugué B; Meunier B; Paoletti C
    Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.